DanCann Pharma A/S appoints Sarah Mai Lykke-Kjeldsen as new COO
COPENHAGEN, Denmark, 28 March 2022 – DanCann Pharma A/S (SS: DANCAN) (“DanCann Pharma” or the “Company”), hereby announce that the Company has appointed Sarah Mai Lykke-Kjeldsen as new Chief Operating Officer (“COO”).DanCann Pharma A/S was formed in 2018 and has since then undergone an extensive development and maturation process. Following the establishment of the Biotech Pharm1 production facilities and last year's acquisition of the wholesale company CannGros ApS, the ambitious pharma company now focuses on strengthening the organization in order to ensure stable future operations.